We are live on ! Find out more
RFCA

R&F Capital Advisors Portfolio holdings

AUM $387M
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$387M
AUM Growth
+$104M
Cap. Flow
+$95.8M
Cap. Flow %
24.75%
Top 10 Hldgs %
9.31%
Holding
915
New
429
Increased
127
Reduced
106
Closed
252

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$3.65M
2
MO icon
Altria Group
MO
+$3.34M
3
ABT icon
Abbott
ABT
+$3.17M
4
COP icon
ConocoPhillips
COP
+$2.84M
5
CBOE icon
Cboe Global Markets
CBOE
+$2.72M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$4.41M
2
CSCO icon
Cisco
CSCO
+$3.75M
3
PCG icon
PG&E
PCG
+$2.96M
4
BBY icon
Best Buy
BBY
+$2.9M
5
MRSH
Marsh
MRSH
+$2.8M

Sector Composition

Rank Sector Weight
1 Financials 15.94%
2 Consumer Discretionary 12.95%
3 Healthcare 12.73%
4 Industrials 11.72%
5 Technology 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PF
76
DELISTED
Pinnacle Foods, Inc.
PF
$1.21M 0.31%
+20,942
New +$1.16M
TAP icon
77
Molson Coors Class B
TAP
$7.77B
$1.2M 0.31%
12,568
-9,002
-42% -$879K
GSK icon
78
GSK
GSK
$101B
$1.18M 0.3%
22,379
-1,216
-5% -$61.7K
VER
79
DELISTED
VEREIT, Inc.
VER
$1.18M 0.3%
27,733
+6,322
+30% +$273K
LEG icon
80
Leggett & Platt
LEG
$1.26B
$1.15M 0.3%
+22,834
New +$1.12M
CFG icon
81
Citizens Financial Group
CFG
$29.6B
$1.15M 0.3%
33,181
+13,557
+69% +$495K
NLY icon
82
Annaly Capital Management
NLY
$17.4B
$1.14M 0.29%
+25,632
New +$1.09M
TEVA icon
83
Teva Pharmaceuticals
TEVA
$43.8B
$1.12M 0.29%
34,954
+27,837
+391% +$950K
STE icon
84
Steris
STE
$22.7B
$1.07M 0.28%
15,482
+10,446
+207% +$723K
FTR
85
DELISTED
Frontier Communications Corp.
FTR
$1.07M 0.28%
33,443
+27,106
+428% +$1.24M
PH icon
86
Parker-Hannifin
PH
$127B
$1.07M 0.28%
6,669
+4,008
+151% +$608K
OMC icon
87
Omnicom Group
OMC
$24.1B
$1.05M 0.27%
+12,142
New +$1.04M
MTN icon
88
Vail Resorts
MTN
$5.15B
$1.04M 0.27%
+5,436
New +$963K
THG icon
89
Hanover Insurance
THG
$7.93B
$1.04M 0.27%
11,578
+5,097
+79% +$451K
COST icon
90
Costco
COST
$415B
$1.03M 0.27%
+6,149
New +$1.03M
UDR icon
91
UDR
UDR
$11.9B
$1.03M 0.27%
+28,419
New +$1.02M
REGN icon
92
Regeneron Pharmaceuticals
REGN
$83.2B
$1M 0.26%
2,594
-2
-0.1% -$741
XOM icon
93
ExxonMobil
XOM
$643B
$1M 0.26%
+12,206
New +$1.02M
BCR
94
DELISTED
CR Bard Inc.
BCR
$998K 0.26%
+4,016
New +$968K
BP icon
95
BP
BP
$109B
$987K 0.26%
+32,775
New +$996K
DLTR icon
96
Dollar Tree
DLTR
$24.4B
$975K 0.25%
+12,428
New +$955K
YUM icon
97
Yum! Brands
YUM
$41.1B
$965K 0.25%
+15,103
New +$983K
BERY
98
DELISTED
Berry Global Group, Inc.
BERY
$964K 0.25%
21,617
+3,398
+19% +$156K
MU icon
99
Micron Technology
MU
$1.06T
$959K 0.25%
33,176
+18,273
+123% +$446K
EW icon
100
Edwards Lifesciences
EW
$51.8B
$951K 0.25%
+30,324
New +$949K

Similar funds

R&F Capital Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, R&F Capital Advisors held 915 positions worth $387M, up 37% from $284M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

R&F Capital Advisors deployed $95.8M of net new capital in Q1 2017, opening 429 new positions and adding to 127 existing holdings. Its largest new stake was Altria Group: 46,162 shares worth $3.3M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Baxter International, an estimated $4.41M trimmed.

  • R&F Capital Advisors's largest Q1 2017 buy was Altria Group: 46,162 shares worth $3.3M.
  • R&F Capital Advisors added most to Goldman Sachs in Q1 2017, an estimated $3.65M increase.
  • R&F Capital Advisors's biggest Q1 2017 reduction was Baxter International, cutting an estimated $4.41M.
  • R&F Capital Advisors fully exited Cisco in Q1 2017, selling an estimated $3.75M.
  • R&F Capital Advisors's ten largest holdings make up 9.3% of its $387M portfolio in Q1 2017.
  • R&F Capital Advisors opened 429 new positions and closed 252 in Q1 2017.
  • R&F Capital Advisors's portfolio value rose 37% quarter-over-quarter to $387M.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.